Agenda: What’s Hot in Boston Biotech

4.8.2016 AGENDA
12:30  1:30Registration & Networking
1:30  1:40Welcome
Bob Buderi, Founder and Editor in Chief, Xconomy
Clare Midgley, Chief Communications Officer, Broad Institute of MIT and Harvard
1:40  1:50Introduction
Adam Koppel, Senior VP and Chief Strategy Officer, Biogen
1:50  2:15Synthetic Biology; From Hype to Disruption
James Collins
, Professor of Medical Engineering & Science, MIT
Amir Nashat, Managing Partner, Polaris Partners
2:15  2:40Upending Neuroscience With Evolution; the Yumanity story
Tony Coles, CEO, Chairman, and Founding Investor, Yumanity Therapeutics
Susan Lindquist, Member, Whitehead Institute; Scientific Founder, Yumanity Therapeutics
2:40  3:10Can Cell Therapy Completely Change Cancer Care?
Chuck Wilson, CEO and President, Unum Therapeutics
Ben Auspitz, Partner, Fidelity Biosciences
3:10  3:35Scaling Entrepreneurial Innovation in Biotechnology
Noubar Afeyan, Managing Partner and CEO, Flagship Venture
3:35 – 4:05Networking Break
4:05 – 4:30Harnessing the Microbiome; the Vedanta story
Bernat Olle, Principal, PureTech Ventures
Marian Nakada, VP of Venture Investments, Johnson & Johnson Innovation
4:30 – 5:00Gene Therapy on the Precipice
Olivier Danos, Senior Vice President, Gene Therapy, Biogen
Steve Paul, President and CEO, Voyager Therapeutics
Peter Kolchinsky, Managing Member and Portfolio Manager, RA Capital Management
Michelle Dipp, Co-founder and CEO, OvaScience (Moderator)
5:00 – 5:30Precision Medicine; Untangling the Web of Interoperability
David Altshuler, Executive VP of Global Research and CSO, Vertex Pharmaceuticals
Alexis Borisy, Chairman, Foundation Medicine; Partner, Third Rock Ventures
Samantha Singer, COO, The Broad Institute of MIT and Harvard (Moderator)
5:30 – 6:30Networking Reception